NCT05439278View on ClinicalTrials.gov

Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma

PHASE3RecruitingINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2030

Conditions
Glioblastoma
Interventions
RADIATION

Hypofractionated radiotherapy

40.05 Gy in 15 fractions (daily treatment, 5 per week)

RADIATION

Conventional radiotherapy

60 Gy in 30 fractions (daily treatment, 5 per week)

DRUG

Temozolomide

concurrent (75 mg/m2/day qd) and adjuvant (6 cycles)

Trial Locations (1)

Unknown

RECRUITING

Severance hospital, Seoul

All Listed Sponsors
lead

Severance Hospital

OTHER